To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy
1 other identifier
interventional
2,193
1 country
1
Brief Summary
Screen-and-treat approach reduces postabortal pelvic inflammatory disease after induced abortion, and at the same time alters women's sexual behavior and prevents further re-infection by sexually transmitted infections when compared to the universal antibiotic prophylaxis strategy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 1999
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 1999
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2006
CompletedFirst Submitted
Initial submission to the registry
April 21, 2013
CompletedFirst Posted
Study publicly available on registry
April 29, 2013
CompletedApril 29, 2013
April 1, 2013
6.4 years
April 21, 2013
April 24, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of postabortal inflammatory disease 6 weeks after induced abortion.
6 weeks after induced abortion.
Secondary Outcomes (2)
Rate of re-infection by sexually transmitted infections 24 weeks after induced abortion.
24 weeks after induced abortion.
Proportion of women having abstinence from sexual intercourse or using condom at 6 weeks, 24 weeks and 1 year after induced abortion.
6 weeks, 24 weeks and 1 year after induced abortion
Study Arms (2)
Universal antibiotic prophylaxis
ACTIVE COMPARATORIn the universal prophylaxis group, all women received doxycycline 100 mg twice daily for 7 days starting on the day of induced abortion. Screening for sexually transmitted diseases was done as baseline but the results were not revealed to the patients.
Screen-and-treat
ACTIVE COMPARATORIn the screen-and-treat group, the results of screening for sexually transmitted infections (STI) were revealed to the patients. They would only receive appropriate specific antibiotics treatment only if they were screened positive for any of the STIs. If they were found to have STI, their sexual partners would also be referred to the local social hygiene clinics for contact tracing and treatment. Contraception by barrier methods would also be advised.
Interventions
100 mg twice daily for 7 days starting on the day of induced abortion
Specific antibiotic treatment was only given if the women was found to have sexually transmitted infection(s) on screening.
Eligibility Criteria
You may qualify if:
- women requesting for induced abortion in the gynecology clinic
You may not qualify if:
- nil
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Queen Mary Hospital
Hong Kong, Hong Kong, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sofie SF Yung, MBBS, MRCOG
The University of Hong Kong
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 21, 2013
First Posted
April 29, 2013
Study Start
September 1, 1999
Primary Completion
February 1, 2006
Study Completion
February 1, 2006
Last Updated
April 29, 2013
Record last verified: 2013-04